Boehringer Ingelheim today announced the start of a Phase IIa clinical trial evaluating BI 765423, a novel monoclonal antibody targeting interleukin-11 (IL-11), in patients with idiopathic pulmonary ...

Public health and school officials say after covid, parents have been more likely to skip the school bus at the first sign of ...

Here are the 40 Under 40 winners this year and an outstanding alumnus who is entering the Hall of Fame.

SAN DIEGO, Jan. 12, 2026 (GLOBE NEWSWIRE) -- ...

Jeff Ruby Culinary Entertainment has agreed to pay more than $1.5 million to settle a class action federal labor lawsuit ...